These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5368513)

  • 21. [Growth in the number of erythrocytes and leukocytes in chemical air pollution].
    Barkov LV; Kazantseva VG; Timoshchuk GI; Tsarik GN; Mikheeva LA
    Gig Sanit; 1982 Aug; (8):10-2. PubMed ID: 7129136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adverse effects of drugs on blood formation. I].
    Libánský J
    Cas Lek Cesk; 1971 Feb; 110(8):183-8. PubMed ID: 5545533
    [No Abstract]   [Full Text] [Related]  

  • 23. [Megaloblastic erythropoiesis in stem cell leukemias].
    Kraus W
    Z Gesamte Inn Med; 1981 Feb; 36(3):82-5. PubMed ID: 7222855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Granulocytopenia and infections during induction therapy of acute leukemia].
    Ly B; Solheim BG; Skar AG
    Tidsskr Nor Laegeforen; 1981 Feb; 101(6):379-86. PubMed ID: 7209927
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antianemic effect of reamberin in rats with acute alloxan-induced diabetes].
    Volchegorskiĭ IA; Tishevskaia NV; Dement'eva EV
    Eksp Klin Farmakol; 2008; 71(6):23-7. PubMed ID: 19140511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drugs as causes of death. Experimental survey of death certificates].
    Ugeskr Laeger; 1969 Feb; 131(9):383-4. PubMed ID: 5772320
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse consequences with use of erythropoiesis-stimulating agents in anemia prompt release of guidelines to ensure safe use and maximize benefit.
    Dharmarajan TS; Widjaja D
    Geriatrics; 2008 Jun; 63(6):13-29. PubMed ID: 18512996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
    Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Indications of G-CSF in patients with drug-induced agranulocytosis].
    Takeda R; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Kuriya S
    Rinsho Ketsueki; 1993 Sep; 34(9):997-1001. PubMed ID: 7693988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Carbamazepine-induced agranulocytosis. Apropos of 2 cases].
    Banfi L; Ceppi M; Colzani M; Guzzini F; Morena R; Novati P
    Recenti Prog Med; 1998 Oct; 89(10):510-3. PubMed ID: 9842254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Megaloblastic maturation disorder of erythropoiesis in plasmacytoma and chronic lymphatic leukemia].
    Kraus W
    Z Gesamte Inn Med; 1982 Feb; 37(3):91-3. PubMed ID: 7080558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meclofenamate sodium-induced agranulocytosis and suppression of erythropoiesis.
    Wishner AJ; Milburn PB
    J Am Acad Dermatol; 1985 Dec; 13(6):1052-3. PubMed ID: 4078095
    [No Abstract]   [Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence and clinical course of drug-induced agranulocytosis in Hungary].
    Bán A; Ambrusics A; Pintér G
    Orv Hetil; 1984 Jan; 125(3):139-44. PubMed ID: 6700977
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck.
    Tsuge I; Suzuki K; Moribe K; Motai H; Kimura T; Umeda K; Kobayashi T; Yokota A; Hondo J; Baba S
    Acta Otolaryngol Suppl; 1996; 525():129-34. PubMed ID: 8908287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bone marrow megaloblastosis associated with the use of pyrimethamine, triamterene and trimethoprim-sulfamethoxazole].
    Anguita T
    Rev Med Chil; 1982 Jun; 110(6):570-9. PubMed ID: 6984535
    [No Abstract]   [Full Text] [Related]  

  • 40. Increase of bone marrow cellularity during erythropoietin treatment in myeloma.
    Ludwig H; Chott A; Fritz E; Krainer M
    Stem Cells; 1995 Aug; 13 Suppl 2():77-87. PubMed ID: 8520516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.